Eledon Pharmaceuticals (ELDN) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free ELDN Stock Alerts $2.31 -0.09 (-3.75%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Eledon Pharmaceuticals Short Interest DataCurrent Short Volume35,400 sharesPrevious Short Volume31,100 sharesChange Vs. Previous Month+13.83%Dollar Volume Sold Short$84,606.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 30, 2024Outstanding Shares24,810,000 sharesPercentage of Shares Shorted0.14%Today's Trading Volume197,005 sharesAverage Trading Volume288,325 sharesToday's Volume Vs. Average68% Short Selling Eledon Pharmaceuticals ? Sign up to receive the latest short interest report for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatELDN Short Interest Over TimeELDN Days to Cover Over TimeELDN Percentage of Float Shorted Over Time Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Eledon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202435,400 shares $84,606.00 +13.8%N/A0.2 $2.39 4/15/202431,100 shares $51,004.00 -70.9%N/A0.3 $1.64 3/31/2024106,900 shares $220,214.00 +193.7%N/A1.4 $2.06 3/15/202436,400 shares $56,056.00 -6.7%N/A0.5 $1.54 2/29/202439,000 shares $70,200.00 -26.7%N/A0.6 $1.80 2/15/202453,200 shares $97,356.00 -11.8%N/A0.8 $1.83 Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202460,300 shares $107,334.00 -15.6%N/A0.8 $1.78 1/15/202471,400 shares $123,529.14 +37.3%N/A0.8 $1.73 12/31/202352,000 shares $93,600.00 -20.4%N/A0.6 $1.80 12/15/202365,300 shares $99,256.00 +147.4%N/A0.7 $1.52 11/30/202326,400 shares $30,360.00 -59.9%N/A0.3 $1.15 11/15/202365,900 shares $82,375.00 +25.8%N/A0.7 $1.25 10/31/202352,400 shares $81,744.00 +5.2%N/A0.6 $1.56 10/15/202349,800 shares $73,704.00 -20.1%N/A0.7 $1.48 9/30/202362,300 shares $85,351.00 +92.3%N/A0.9 $1.37 9/15/202332,400 shares $40,500.00 +18.7%N/A0.6 $1.25 8/31/202327,300 shares $41,496.00 -34.4%N/A0.5 $1.52 8/15/202341,600 shares $50,752.00 +1.2%N/A0.5 $1.22 7/31/202341,100 shares $56,718.00 +18.1%N/A0.3 $1.38 7/15/202334,800 shares $50,112.00 -4.1%N/A0.2 $1.44 6/30/202336,300 shares $49,731.00 -85.1%N/A0.2 $1.37 6/15/2023244,200 shares $402,930.00 +383.6%2.0%1.3 $1.65 5/31/202350,500 shares $106,050.00 +136.0%0.4%0.3 $2.10 5/15/202321,400 shares $49,648.00 -62.6%0.2%0.1 $2.32 4/30/202357,200 shares $120,120.00 +276.3%0.4%0.5 $2.10 4/15/202315,200 shares $37,088.00 -47.0%0.1%0.6 $2.44 3/31/202328,700 shares $67,732.00 +64.9%0.2%1.1 $2.36 3/15/202317,400 shares $34,974.00 +4.2%0.1%0.8 $2.01 2/28/202316,700 shares $39,412.00 -9.2%0.1%1 $2.36 2/15/202318,400 shares $49,864.00 +8.2%0.1%1.2 $2.71 1/31/202317,000 shares $56,440.00 +6.3%0.1%1.1 $3.32 1/15/202316,000 shares $45,561.60 +11.9%0.1%1.1 $2.85 12/30/202214,300 shares $32,604.00 +19.2%0.1%0.7 $2.28 12/15/202212,000 shares $28,972.80 -39.7%0.1%0.6 $2.41 11/30/202219,900 shares $48,556.00 -20.1%0.1%1 $2.44 11/15/202224,900 shares $65,736.00 +69.4%0.2%1.1 $2.64 10/31/202214,700 shares $35,427.00 -2.0%0.1%0.6 $2.41 10/15/202215,000 shares $37,992.00 -29.9%0.1%0.6 $2.53 9/30/202221,400 shares $59,064.00 -4.9%0.2%0.7 $2.76 9/15/202222,500 shares $76,500.00 -17.6%0.2%0.7 $3.40Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ELDN Short Interest - Frequently Asked Questions What is Eledon Pharmaceuticals' current short interest? Short interest is the volume of Eledon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 35,400 shares of ELDN short. Learn More on Eledon Pharmaceuticals' current short interest. Is Eledon Pharmaceuticals' short interest increasing or decreasing? Eledon Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 35,400 shares, an increase of 13.8% from the previous total of 31,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Eledon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Eledon Pharmaceuticals: BioLineRx Ltd. (0.51%), Celularity Inc. (5.64%), Reneo Pharmaceuticals, Inc. (13.80%), Annovis Bio, Inc. (14.62%), Immix Biopharma, Inc. (2.80%), CalciMedica, Inc. (0.93%), Gain Therapeutics, Inc. (1.02%), Checkpoint Therapeutics, Inc. (11.50%), Aadi Bioscience, Inc. (6.50%), Kezar Life Sciences, Inc. (5.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Eledon Pharmaceuticals stock? Short selling ELDN is an investing strategy that aims to generate trading profit from Eledon Pharmaceuticals as its price is falling. ELDN shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eledon Pharmaceuticals? A short squeeze for Eledon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELDN, which in turn drives the price of the stock up even further. How often is Eledon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELDN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BioLineRx Short Interest Data Celularity Short Interest Data Reneo Pharmaceuticals Short Interest Data Annovis Bio Short Interest Data Immix Biopharma Short Interest Data CalciMedica Short Interest Data Gain Therapeutics Short Interest Data Checkpoint Therapeutics Short Interest Data Aadi Bioscience Short Interest Data Kezar Life Sciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELDN) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingGlobal crypto currency reset (41 major banks signed up)Stansberry Research